Category: 3. Business

1. The Activities overview page is all grown up

When the Activities overview page first appeared in LMS 5.0, we were thrilled to have a place to go to easily see all course activities — and their due dates, etc. — all in one place. When the Activities overview page debuted, only the Assignment activity was fully supported (teachers could easily see what they needed to grade, and learners could easily see what they needed to do).

But in LMS 5.1, this gets even better. Now the Activities overview page works across all the major activities — forums, quizzes, H5P, wikis, lessons, glossaries, even BigBlueButton sessions.

Why this matters: Instead of being just a tidy list, this page now acts like a real command centre. Teachers can see what needs grading or follow-up without digging around. Learners see their progress laid out clearly: what’s done, what’s next. That’s a big deal for reducing confusion.

PRINCETON, N.J. and CAMBRIDGE, Mass., Oct. 12, 2025 /PRNewswire/ — Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced new data from the central nervous system (CNS) involvement cohort of the REZILIENT2 study of zipalertinib, an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations (ex20ins) or uncommon non-ex20ins EGFR mutations and CNS involvement. Data will be presented at the European Society for Medical Oncology (ESMO) Congress 2025, as a mini oral presentation on October 19 during the “NSCLC metastatic” session from 8:30 to 10 a.m. CEST.

The mini oral presentation will highlight preliminary efficacy and safety data from the CNS involvement cohort of the ongoing parallel cohort Phase 2b REZILIENT2 trial of zipalertinib.¹

Patients with locally advanced or metastatic NSCLC harboring EGFR ex20ins mutations represent a significant unmet medical need. An incidence of baseline brain metastases in EGFR ex20ins NSCLC patients ranging from 23% to 39% has been reported.² Patients with lung cancer with CNS involvement have a worse prognosis and require more aggressive therapy, including surgery and radiotherapy.

“Treatment options are limited for patients with NSCLC with EGFR mutations and active brain metastases,” said Helena A. Yu, MD, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer. “We are pleased to see that in approximately one-third of patients exposed to zipalertinib, a decrease in CNS lesions was observed. These preliminary results suggest the potential for zipalertinib to treat these patients, warranting future investigation.”

Authors will report results from the REZILIENT2 study of zipalertinib against active CNS metastases in patients with NSCLC harboring EGFR ex20ins or other uncommon mutations¹:

Summary of Preliminary Efficacy – by Investigator

As of the February 2025 data cutoff, 32 patients were enrolled in the CNS involvement cohort of the ongoing parallel cohort Phase 2b REZILIENT2 trial and received zipalertinib 100 mg orally twice daily. Patients received a median of 2 prior lines of therapy, and of all patients enrolled, 21 patients had ex20ins mutations and 13 patients had other uncommon mutations.

 As of the data cutoff, zipalertinib demonstrated:

• In the Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) criteria evaluable population with measurable CNS disease (n=16, including 3 patients with leptomeningeal disease (LMD), intracranial objective response rate was 31.3% including 1 intracranial complete response.
• In the same population, the intracranial disease control rate (iDCR) was 68.8% and the median intracranial duration of response (DOR) was 8.1 months.
• Measured in 29 of the cohort’s patients, preliminary systemic objective response rate (ORR) was 27.6% and median DOR was 7.6 months.
• Intracranial antitumor activity was found to be similar to its overall systemic anticancer activity in this cohort of patients.

Summary of Preliminary Safety and Tolerability

Administered at 100 mg orally twice daily, zipalertinib was found to be well tolerated, with no new safety signals observed.

Treatment-related adverse events of grade 3 or higher occurred in 8 patients (25%) and included anemia (n=3) and interstitial lung disease (n=2). There was one death due to interstitial lung disease.

About REZILIENT2
REZILIENT2 is a Phase 2b clinical trial (NCT05967689), evaluating the safety and efficacy of zipalertinib in patients with locally advanced or metastatic NSCLC harboring ex20ins mutations or other uncommon/single or compound EGFR mutations. Patients are enrolled into one of four cohorts: Cohort A (“prior ex20ins treatment”), Cohort B (“first-line”), Cohort C (“active brain metastases”), and Cohort D (“other uncommon EGFR mutations”). Cohort C includes patients harboring EFGR ex20ins or other uncommon/single or compound EGFR mutations and CNS involvement. In this cohort, patients may or may not have had prior treatment for advanced disease. Patients are treated with oral zipalertinib 100 mg twice daily. The primary endpoint is ORR and confirmed per investigator-assessed Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 and the secondary endpoints include DOR, DCR, PFS, OS, intracranial efficacy by RANO-BM criteria, PK and safety.

About Zipalertinib
Zipalertinib (development code: CLN-081/TAS6417) is an orally available small molecule designed to target activating mutations in EGFR. The molecule was selected because of its ability to inhibit EGFR variants with ex20ins mutations, while sparing wild-type EGFR. Zipalertinib is designed as a next generation, irreversible EGFR inhibitor for the treatment of a genetically defined subset of patients with non-small cell lung cancer. Zipalertinib has received Breakthrough Therapy Designation from the FDA. Zipalertinib is investigational and has not been approved by any health authority.

Zipalertinib is being developed by Taiho Oncology, Inc., its parent company, Taiho Pharmaceutical Co., Ltd., and in collaboration with Cullinan Therapeutics, Inc. in the U.S.

About Taiho Oncology, Inc.
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development and commercialization of orally administered anti-cancer agents for various tumor types. Taiho Oncology has a robust pipeline of small-molecule clinical candidates targeting solid-tumor and hematological malignancies, with additional candidates in pre-clinical development. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Baar, Switzerland and Oakville, Ontario, Canada.

For more information, visit https://www.taihooncology.com/, and follow us on LinkedIn and X.

Taiho Oncology and the Taiho Oncology logo are registered trademarks of Taiho Pharmaceutical Co., Ltd.

About Cullinan Therapeutics
Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients. Cullinan has strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both autoimmune diseases and cancer. Cullinan’s portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of autoimmune and cancer indications. We push conventional boundaries from candidate selection to differentiated therapeutic, applying rigorous go/no go criteria at each stage of development to fast-track only the most promising molecules to the clinic and, ultimately, commercialization. With deep scientific expertise, our teams exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients. Learn more about Cullinan at https://cullinantherapeutics.com/, and follow us on LinkedIn and X.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding the company’s beliefs and expectations regarding our plans regarding future data presentations, the clinical development and regulatory filing plan and timeline of zipalertinib, the safety and efficacy profile of zipalertinib and its potential to address unmet medical need, and other statements that are not historical facts. The words “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “plan,” “potential,” “project,” “pursue,” “will,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Any forward-looking statements in this press release are based on management’s current expectations and beliefs of future events and are subject to known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks include, but are not limited to, the following: uncertainty regarding the timing and results of regulatory submissions; the risk that any NDA or other regulatory submissions we may file with the United States Food and Drug Administration or other global regulatory agencies are not cleared on our expected timelines, or at all; the success of our clinical trials and preclinical studies; the risks related to our ability to protect and maintain our intellectual property position; the risks related to manufacturing, supply, and distribution of our product candidates; the risk that any one or more of our product candidates, including those that are co-developed, will not be successfully developed and commercialized; the risk that the results of preclinical studies or clinical studies will not be predictive of future results in connection with future studies; and the success of any collaboration, partnership, license or similar agreements. These and other important risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in our most recent Annual Report on Form 10-K and subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change, except to the extent required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release. Moreover, except as required by law, neither the company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements included in this press release. Any forward-looking statement included in this press release speaks only as of the date on which it was made.

Contacts

Taiho Oncology

Leigh Labrie
(609) 664-9878
[email protected]

Cullinan Therapeutics

Investors 
Nick Smith
+1 401.241.3516
[email protected]

Media
Rose Weldon
+1 215.801.7644
[email protected]

References

1. K. Ohashi et al. Activity of Zipalertinib Against Active Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Exon 20 Insertion (Ex20ins)/Other Uncommon Mutations.
2. Remon J. et al. EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins. Cancer Treatment Review. Volume 90, November 2020, 102105.

SOURCE Taiho Oncology

Sign up here.

The firm noted that depletion for its Penfolds business “remains weak relative to plan”, with the firm now no longer retaining its guidance for the same for low to mid double-digit EBITS growth in fiscal 2026 and approximately 15% EBITS growth in fiscal 2027.

Similarly, given the uncertain outlook around trading conditions and expectations, Treasury Wine said it is prudent to pause the buyback until greater clarity is available.

“Several initiatives are now being implemented to mitigate the expected impacts in China in F26, including pursuing opportunities to re-allocate product to select customers in other key markets in a manner that is sustainable and minimises the risk of parallel imports back into the China market,” the winemaker added in its statement.

($1 = 1.5382 Australian dollars)

Our Standards: The Thomson Reuters Trust Principles., opens new tab

By David Winning

  SYDNEY--Mining software company RPM Global said it has agreed to a takeover by U.S. giant Caterpillar that values its equity at some 1.12 billion Australian dollars (US$730 million). 

  RPM Global said Caterpillar is offering A$5.00 per share in cash. That represents a 33% premium to RPM Global's share price on Aug. 28, just before it announced Caterpillar was interested in acquiring the company. 

  Denise Johnson, Caterpillar's president of Resource Industries, said RPM Global's software complements its own technologies, especially in areas such as asset management, fleet management and autonomy. 

  "Together, we have the potential to enhance mine site operations for our customers, unlocking even greater value," Johnson said. 

  Write to David Winning at david.winning@wsj.com 

  (END) Dow Jones Newswires

  October 12, 2025 17:50 ET (21:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.

Story Continues

The MAS uses the exchange rate as its policy tool to curb inflation and support growth, given Singapore’s trade-dependent economy. Separately, Singapore will also release its September nonoil domestic exports data on Friday.

  Malaysia 

  Malaysia will release third-quarter advance GDP figures and September trade data. Economic growth likely slowed to 4.3% in the third quarter from 4.4% in the previous quarter, as leading indicators point to weaker private consumption and softer imports of consumer goods, ANZ economists said. 

  While business approvals rose sharply in the first half, sentiment weakened in the third quarter across manufacturing and services, and slower capital goods imports suggest softer investment growth. Nominal imports fell faster than exports, likely improving net export slightly, though external demand remains subdued, ANZ added. The bank maintained its full-year growth forecast at 4.3%. 

  Malaysia's export growth may remain subdued in September amid global uncertainty and U.S. tariffs imposed in August, said TA Securities analyst Farid Burhanuddin. However, Malaysia's diversified export base, particularly strong trade ties with Asean, China, and other emerging markets, should help offset weaker U.S. demand, he added. 

  India 

  India will release inflation data on Monday, which is widely expected to show that price growth has resumed cooling after an uptick in August. A CPI print below the central bank's target could fuel expectations for more rate cuts ahead. 

  DBS economists forecast headline inflation to have eased to 1.5% on year in September from 2.1% the month before, taking the quarterly average slightly below the RBI's projected 1.8%. 

  "Global energy prices have also been subdued, offsetting the spillover risks from a weak rupee, while precious metals continue to stay buoyant," they said. 

  Wholesale price index data on Tuesday will round out the inflation picture. On Wednesday, attention will turn to trade figures for September, as India remains in talks with the U.S. over tariffs. DBS economists expect exports to moderate, leaving the trade deficit wide at $24 billion. 

  Any references to days are in local times. 

  Write to Emese Bartha at emese.bartha@wsj.com and Jihye Lee at jihye.lee@wsj.com 

  (END) Dow Jones Newswires

  October 12, 2025 17:14 ET (21:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.

The school developed the Business Success program in consultation with business leaders across the country. The goal is to help business students address skill gaps and become more competitive in the job market.

“The program should set our students apart from the competition and provide additional certification that our students are ‘business ready,'” said Ken Cyree, dean of the School of Business Administration. “We greatly appreciate our alumni and business partners in helping us tailor the program and teach the courses so our students will maximize their chances for success.”

The first workshop, on Sept. 23, drew some 30 students and focused on critical thinking. Bill Fry, an Ole Miss alumnus and managing director of American Securities Capital, led the session and used examples from his journey to define critical thinking.

“The Business Success meeting on critical thinking really challenged me to think more intentionally about how I approach problems both inside and outside the classroom,” said Sophia Honnald, a junior marketing major from Rumson, New Jersey, who is minoring in entrepreneurship. “It was engaging to hear different perspectives from peers and faculty on how critical thinking plays such a major role in business decision-making.”

The program began with an idea from Ole Miss graduates and retired businessmen Bill Andrews and Jeff Rogers, both Oxford residents. The two former Business Advisory Board members pitched the idea to Cyree to help students complete their skill sets and begin networking while still in school.

“The students’ opportunity to learn, interact and connect with industry leaders is a unique and valuable part of Business Success,” Rogers said. “Relationships matter, and the students have the opportunity to establish special relationships to guide them in their career.”

Andrews and Rogers interviewed 20 industry leaders about areas where students could differentiate themselves from their competition in the job market and to brainstorm workshop programming ideas. They developed four test modules and offered them to students last spring, earning positive feedback from both students and industry leaders.

Cyree approved the program for eight modules in the 2025-26 academic year. These modules cover topics including communication skills, business etiquette and critical thinking. Students who attend six of the eight modules earn a certificate of acknowledgement.

The second Business Success module is set for Oct. 14 in the Jackson Avenue Center. This workshop focuses on building communication skills and will be led by Sparky Reardon, former UM dean of students.

The program continues through the spring:

• 28 – Business Etiquette
• 11 – Real-World Problems
• 18 – Real World Problems
• 3 – Critical Thinking
• 17 – Thinking Like an Owner
• March 3 – Discovering Your Passion Celebration Dinner.

All sessions run from 4 to 5 p.m. in the Jackson Avenue Center, Room 103.

“The sign-up for the Business Success certificate program is verifying that Dean Cyree was 100% on target with his vision for what it would do for Ole Miss business school students,” Andrews said. “Ole Miss students will begin their careers with a clear understanding of the traits that will propel them to the top of their chosen field.”

To register or learn more about a Business Success session, contact Bailey Bracken at bobracke@olemiss.edu.

Top: Bill Fry, a 1980 alumnus of the School of Business Administration, shares experiences from his career during the first workshop of the new Business Success program. Fry, of Bluffton, South Carolina, is a member of the school’s Hall of Fame with a service award for his numerous contributions. Photo by Frank Estrada/School of Business Administration

Airports in the Gulf region and Türkiye have experienced a surge in air passenger traffic. As they compete to be key transit hubs and main tourist and business destinations, high-performance Wi-Fi networks have become increasingly important in shaping the overall passenger experience. We use Speedtest Intelligence® data to evaluate the Wi-Fi performance of the busiest airports in the region between January and August 2025. These insights help to inform travelers where they are more likely to have the best online experience while transiting through an airport in the region or waiting at a lounge to embark on an outbound flight. 

Key Takeaways:

• King Khalid International Airport in Riyadh (RUH) achieves top-tier public Wi-Fi download speeds of over 86 Mbps. Wi-Fi performance in airports across the Gulf region and Türkiye varies significantly, with RUH offering strong public Wi-Fi speeds ahead of Hamad International Airport in Doha (DOH) and Dubai International Airport (DXB). Kuwait International Airport (KWI) and Zayed International Airport in Abu Dhabi (AUH) fall in the mid-range of download speeds, and the two airports in Istanbul, IST and Sabiha Gokcen (SAW), lag considerably. 
• Very few airport lounges provide superior Wi-Fi performance compared to the general public airport networks. The fastest lounges, such as those in IST and DXB, exhibit a substantial increase in download speeds, 5X for the former and 2X for the latter, compared to public airport Wi-Fi. Top lounges in other airports, such as at RUH and Zayed International Airport in Abu Dhabi (AUH), offer more modest speed gains. Without the ability to demonstrate superior Wi-Fi performance, lounge operators are missing out on a point of differentiation to add to comfort and other amenities.
• Wi-Fi performance differs greatly between lounges, even within the same airport. This suggests that the specific lounge operator plays a crucial role in determining the quality of the Wi-Fi experience. For instance, in Riyadh (RUH), the Al Fursan lounge significantly outperforms the Plaza Premium and HAYYAK lounges. Similarly, in Dubai (DXB), the Marhaba lounge boasts much faster speeds than the Emirates (EK) lounge or the DIH lounge. Lounge operators must address these performance gaps to remain competitive, attract high-value customers, and enhance guest experience and satisfaction.

Wi-Fi performance varies significantly across Middle East and Türkiye airports

Airline passengers today expect seamless connectivity, from check-in to landing. That is why airport operators need to understand how passengers (and staff) access the internet throughout the venue, and ensure their infrastructure meets their connectivity needs. 

In January 2025, Ookla® analyzed the cellular performance at the busiest airport in the Gulf region and Türkiye. We found that Abu Dhabi’s Zayed International Airport (AUH) achieved top-tier median mobile download speeds of over ​​450 Mbps. In comparison, Istanbul Airport (IST) significantly leads in 5G performance, with download and upload speeds of 861.98 Mbps and 101.96 Mbps, respectively.

This time, we used Speedtest Intelligence data to understand whether the public Wi-Fi networks and lounges of the nine busiest airports in the Middle East and Türkiye deliver the kind of internet experience travelers expect—whether that’s for streaming, video calls, or quick file uploads. We compared median Wi-Fi download and upload speeds at each location over a period of eight months (January to August 2025).

Ookla’s data shows that Wi-Fi performance varies greatly from airport to airport. King Khalid International Airport in Riyadh (RUH) has the highest download speed at 86.34 Mbps, placing it at the top of the list, while its upload speed is a more moderate 25.48 Mbps. In contrast, Hamad International Airport in Doha (DOH) and Dubai International Airport (DXB) demonstrate high upload speeds; Dubai leads with 101.86 Mbps, and Doha follows closely at 96.45 Mbps. DXB and DOH also stand out because they are the only two airports where upload speed is higher than download speed.

The two airports in Istanbul, IST and Sabiha Gokcen (SAW), generally have the lowest speeds. IST has a download speed of 22.65 Mbps and an upload speed of 22.20 Mbps, while SAW ranks at the bottom for both metrics, with a download speed of 9.69 Mbps and an upload speed of 9.52 Mbps.

Other airports, like Kuwait International Airport (KWI) and Zayed International Airport in Abu Dhabi (AUH), fall in the mid-range for download and upload speeds. At the same time, Sharjah International Airport (SHJ) and Muscat International Airport (MCT) show slower, sub-30 Mbps download speeds.

A few airport lounges offer better Wi-Fi performance than public airport networks, but the majority need improvements 

Good Wi-Fi in airport lounges is essential for enhancing the travel experience, especially as their popularity grows. With more travelers seeking comfort and productivity during layovers, the demand for reliable internet access has never been higher.

Airport and airline companies position lounges as distinctive features to cater to the needs of business travelers, families, and leisure travelers. A survey by Airport Dimensions revealed that lounge users enjoy the airport more than non-users. Lounge visits are common among frequent travelers in the Middle East, with 66% of those in the U.A.E. and 60% in Saudi Arabia utilizing lounges during their trips. This trend is driven by various factors, including the desire for a more comfortable environment and the availability of amenities, but also the increasing number of financial institutions that incorporate premium travel-related benefits such as lounge access into their loyalty strategies. 

Lounges typically offer dedicated and faster Wi-Fi than the general airport network, making them an attractive option for business travelers and those looking to maximize productivity. Hamad International Airport in Doha is the exception where a single public Wi-Fi network is deployed and accessible to everyone, including inside the lounges. 

We used Speedtest Intelligence data again to examine the download speed that is typically experienced at different airport lounges, and we selected the venues with the highest number of samples, indicating more popularity. Note that we have excluded Kuwait International Airport (KWI) or Sharjah International Airport (SHJ), as there were no Speedtest samples captured that were associated with lounges in these two locations. We have also aggregated samples from different lounges within the same airport that share the same Wi-Fi Service Set Identifier (SSID). 

Ookla data suggests that the fastest lounge’s Wi-Fi performance in all airports is superior to that of the general public Wi-Fi network. The most dramatic difference is at Istanbul Airport (IST), where the YOTEL lounge Wi-Fi clocks in at 119.46 Mbps, while the public Wi-Fi lags far behind at 22.65 Mbps. Similarly, airports in Riyadh (RUH) and Dubai (DXB) show substantial advantages for Saudia’ Al Fursan and Marhaba lounge users over the free public Wi-Fi, with lounge speeds reaching 120.5 Mbps and 101.98 Mbps, respectively.

The Pearl Lounge in Abu Dhabi Airport (AUH) shows the smallest speed increase over the free Wi-Fi network. At the other end of the spectrum, Istanbul’s Sabiha Gökçen Airport (SAW) recorded the slowest speeds for lounge Wi-Fi at 25.8 Mbps, lagging the other airports in public Wi-Fi ranking.

Wi-Fi performance across lounges in the same airport exhibits strong variation, emphasizing that the choice of a lounge could be a critical factor for travelers needing a fast internet connection. In Riyadh’s RUH, the Al Fursan lounge delivers a fast median download speed of 120.5 Mbps, contrasting strongly with Plaza Premium and HAYYAK lounges in the same airport, which offer sub-22 Mbps speeds. A similar, though less extreme disparity can be observed in Istanbul Airport (IST), where YOTEL lounges provide a download speed that is more than double that of the iGA lounge at 48.32 Mbps. 

Dubai International Airport (DXB) is another example of substantial intra-airport variability. While Marhaba lounge boasts a speed of nearly 101.98 Mbps, airline Emirates’s (EK) lounges provided slower download speeds of just over 60 Mbps. The Dubai International Hotel (DIH) lounge offers a mere 29.16 Mbps download speed at the same location.

Airports like Abu Dhabi (AUH) and Muscat (MCT) exhibit more consistent, albeit moderate, speeds across their lounge offerings in the 40-55 Mbps range; still, it is faster than the public airport Wi-Fi. The Plaza Premium Lounge in Istanbul (SAW) offers slightly better Wi-Fi than the public Wi-Fi but still lags behind the other lounges, except its sister lounge in Abu Dhabi.

The surge in air passenger traffic and growing demand for seamless connectivity underscore a critical need for airport operators and lounge managers to prioritize and invest in their Wi-Fi infrastructure to enhance their overall experience and gain a competitive edge. Our analysis of the busiest airports in the Gulf region and Türkiye shows that while some locations offer high-performance Wi-Fi networks, the variability in speeds across different venues and even within the same airport’s lounges highlights significant opportunities for improvement. 

Airport authorities and lounge operators must actively monitor and enhance their Wi-Fi capabilities to meet and exceed traveler expectations and differentiate their offerings in a competitive market. By doing so, they can unlock new growth opportunities, improve customer loyalty, and strengthen their position as major global travel hubs.

Please contact us for more details on how tools such as Speedtest Intelligence can help provide actionable insights into network performance and become Speedtest Certified™ to publicly demonstrate your commitment to delivering top-tier internet experiences for every traveler. 

Ookla retains ownership of this article including all of the intellectual property rights, data, content graphs and analysis. This article may not be quoted, reproduced, distributed or published for any commercial purpose without prior consent. Members of the press and others using the findings in this article for non-commercial purposes are welcome to publicly share and link to report information with attribution to Ookla.

About the Author

Karim Yaici

Karim Yaici is the Lead Industry Analyst at Ookla covering the Middle East and Africa (MEA) region. Previously, he directed Analysys Mason’s MEA research program, where he was responsible for telecoms forecasts, market reports, consumer surveys, and custom research.